Navigation
banner

ImmunoTX Summit 2017

2017-11-172017-03-142017-02-15
Register 3 for the price of 2 with the coupon code rcdvb!


registration button

Subscribe for updates




Dear Colleague,

We invite you to GTCbio’s ImmunoTX Summit, which takes place on February 6-7, 2017 in San Diego, CA. The summit will bring together our usual balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain a fresh perspective on the various topics below.

15th Cytokines & Inflammation

This conference has become an established meeting point for academic scientists, industry clinical developers, and government researchers to discuss complementary approaches in the field of cytokine biology. Some focused topics we will discuss include developments in the therapeutic application of cytokines and proposal of new targets, the complex relationship between the immune system and microbes in the homeostasis of mucosal tissues, novel means to modulate immune pathways to promote anti-tumor activity, and many more.

9th Immunotherapeutics & Immunomonitoring

Leading experts from the scientific and clinical arenas and industry will present novel findings and developments in the constantly-changing area of immunological assays and procedures. They will also discuss recent advances in immunotherapy as they relate to various immunotherapy modalities, specific cancers, cell subsets, animal models, and tumor microenvironment. Potential clinical feasibility and commercial potential of the newest data obtained from leading biomedical research laboratories will also be discussed.

5th Immunogenicity & Immunotoxicity

We will provide guests with a better understanding of the ongoing research for tools to mitigate risks associated with the immunogenicity of therapeutic proteins. Guests will get an up-to-date understanding of the mechanisms and consequences of protein aggregation and insights on how to prosecute state-of-the-art assessment of the clinical immunogenicity of therapeutic proteins.


Best regards,

The 2017 Organizing Committee

2017 Advisory Board Members
Christopher Heery, NIH
Douglas G McNeel, University of Wisconsin
Ravi Madan, NIH
Richard Kornbluth, Multimeric Bio
Sanjay Khare, Immungene
Paul Moore, Macrogenics
John Janik, GRU Cancer Center
Bruce Freimark, Peregrine
Keith L. Knutson, Mayo Clinic